Press Release: Reprogenetics : Reprogenetics Pioneers New Test, MitoGrade(TM), to Help Select Embryos More Likely to Result in Viable Pregnancies Through In Vitro Fertilization (IVF)
Newly Published Research Demonstrates Increased Levels of Mitochondrial DNA May Explain Why Up to One-Third of Implantations Fail When Transferring a Chromosomally Normal Embryo
Read full article »
CEO
Reprogenetics is a genetics laboratory specializing in preimplantation genetic screening and pre implantation genetic diagnosis in the United States.
Read more